![]() |
|
|
Vol. 288, Issue 2, 414-420, February 1999
-D-Glucuronide:
Effects of Dibromosulfophthalein on Membrane Transport and Aglycone
Formation1
Department of Clinical Pharmacology, The Queen Elizabeth Hospital,
Woodville, South Australia and Department of Clinical and Experimental
Pharmacology, The University of Adelaide, Adelaide, South Australia
(L.S., B.C.S.); and
Centre for Pharmaceutical Research, School of
Pharmacy and Medical Sciences, University of South Australia, Adelaide,
South Australia (A.M.E., R.L.N.)
The liver plays an important role in the disposition of acyl
glucuronides by determining their extent of formation, biliary excretion, and efflux into blood. Thus, both intrahepatic and extrahepatic exposure to these reactive polar conjugates depends on the
efficiency of hepatic transport mechanisms, which may be shared with
other nonbile acid organic anions. Using the isolated perfused rat
liver preparation, the hepatic disposition of the acyl glucuronide,
1-O-gemfibrozil-
-D-glucuronide, was
examined in the presence of the organic anion dibromosulfophthalein
(DBSP). Using a recirculating system, livers were perfused for 90 min with an erythrocyte-free perfusion medium containing 1% (w/v) albumin
and 1-O-gemfibrozil-
-D-glucuronide (3 µM) alone (n = 6) or with DBSP (200 µM,
n = 7). The glucuronide was avidly taken up by the
liver, excreted into bile, and hydrolyzed within the liver to its
aglycone, gemfibrozil. DBSP significantly (P < .05) lowered the conjugate's mean hepatic clearance (8.98-5.17
ml/min), intrinsic clearance (44.0-17.7 ml/min), and fraction
eliminated in bile (72.8-48.7% of the dose), while increasing
perfusate gemfibrozil concentrations (0.52-0.92 µM at 90 min).
Furthermore, DBSP significantly (P < .05) lowered
the ratio of intrahepatic to unbound perfusate concentrations of
1-O-gemfibrozil-
-D-glucuronide
(139.0-35.0) and showed a trend to lower the ratio of bile to
intrahepatic concentrations (111.3-76.2, P = .05).
Thus, the study demonstrated that DBSP inhibited both the sinusoidal
uptake and canalicular transport of
1-O-gemfibrozil-
-D-glucuronide,
suggesting that the hepatic membrane transport of acyl glucuronides is
carrier mediated and shared with other organic anions.
This article has been cited by other articles:
![]() |
Y. Shitara, M. Hirano, H. Sato, and Y. Sugiyama Gemfibrozil and Its Glucuronide Inhibit the Organic Anion Transporting Polypeptide 2 (OATP2/OATP1B1:SLC21A6)-Mediated Hepatic Uptake and CYP2C8-Mediated Metabolism of Cerivastatin: Analysis of the Mechanism of the Clinically Relevant Drug-Drug Interaction between Cerivastatin and Gemfibrozil J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 228 - 236. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Sallustio and F. L. Holbrook In Vivo Perturbation of Rat Hepatocyte Canalicular Membrane Function by Diclofenac Drug Metab. Dispos., December 1, 2001; 29(12): 1535 - 1538. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Sabordo, B. C. Sallustio, A. M. Evans, and R. L. Nation Hepatic Disposition of the Acyl Glucuronide 1-O-Gemfibrozil-beta -D-glucuronide: Effects of Clofibric Acid, Acetaminophen, and Acetaminophen Glucuronide J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 44 - 50. [Abstract] [Full Text] |
||||